• Women in the Behavioral Health Industry: Why Executive Leadership Needs a New, Female Face

    When universal education activist and Nobel Prize laureate Malala Yousafzai addressed the United Nations in 2013, she pointed out that “we cannot all succeed when half of us are held back.” Her words resonated with women’s rights advocates as she boldly confronted an inequity that still needs to be addressed today, especially in the behavioral health field.


  • Continuing Care Plan Adherence Following Residential Addiction Treatment

    Common sense suggests that greater patient adherence to substance use disorder (SUD) treatment recommendations is associated with better outcomes. Surprisingly, however, there is limited previous research systematically investigating the adherence-outcome relationship in the context of SUD treatment.


Darryl  Inaba

Current Director of Clinical and Behavioral Health Service, Addictions Recovery Center, Medford Oregon and Director of Research and Education at CNS Productions, Inc. in Medford Oregon. Dr. Inaba is a Lifetime Fellow at Haight Ashbury Free Clinics in San Francisco and Associate Clinical Professor of Pharmacy at the University Of California San Francisco School of Pharmacy.  While working at the Haight-Ashbury Clinics, Dr. Inaba supervised the clinical treatment of over 300,000 self-referred substance abusers.  He is also noted for his work in developing culturally consistent treatment services with the National Asian Pacific American Families Against Substance Abuse and the Glide Memorial Churchs African American Extended Family Recovery Center in San Francisco.  He has received over 90 individual awards of merit including awards from the California Society of Addiction Medicine and the California Association of County Drug Program Administrators. Dr. Inaba is the author of several publications and award winning educational videos on all aspects of substance abuse work. He is co-author with William Cohen of Uppers, Downer, All Arounders (8th Edition) that is used as the principal text on substance use disorders in over 400 U.S. universities and has been translated in over 6 foreign languages.